XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Series C Preferred Stock
Series B Preferred Stock
 [3]
Preferred Stock
Series C Preferred Stock
Preferred Stock
Series B Preferred Stock
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Series C Preferred Stock
Accumulated Deficit
Accumulated Deficit
Series C Preferred Stock
 [3]
Accumulated Deficit
Series B Preferred Stock
 [3]
Accumulated Other Comprehensive Income
Revision of Prior Period, Accounting Standards Update, Adjustment
Revision of Prior Period, Accounting Standards Update, Adjustment
Accumulated Deficit
Balance (in shares) at Dec. 31, 2018         8,000,000 449,787,000                
Balance at Dec. 31, 2018 $ 3,416,101       $ 80 $ 4,498 $ 3,623,275   $ (632,040)     $ 420,288    
Increase (Decrease) in Stockholders' Equity                            
Net income/(loss) 88,857               88,857          
Issuance of stock, net of expenses (in shares)           1,066,000                
Issuance of stock, net of expenses 551         $ 7 544              
Repurchase of shares of common stock (in shares) [1]           (370,000)                
Repurchase of shares of common stock [1] (2,610)           (2,610)              
Equity based compensation expense 992           992              
Accrued dividends attributable to stock-based awards 435           435              
Dividends declared on common stock (90,097)               (90,097)          
Dividends declared on preferred stock (3,750)               (3,750)          
Dividends attributable to dividend equivalents (256)               (256)          
Change in unrealized gains on MBS, net 5,094                     5,094    
Derivative hedging instrument fair value changes and amortization, net (10,786)                     (10,786)    
Balance (in shares) at Mar. 31, 2019         8,000,000 450,483,000                
Balance at Mar. 31, 2019 3,404,531       $ 80 $ 4,505 3,622,636   (637,286)     414,596    
Balance (in shares) at Dec. 31, 2018         8,000,000 449,787,000                
Balance at Dec. 31, 2018 3,416,101       $ 80 $ 4,498 3,623,275   (632,040)     420,288    
Increase (Decrease) in Stockholders' Equity                            
Net income/(loss) 277,496                          
Dividends declared on preferred stock (11,250)                          
Changes in fair value of financing agreements at fair value due to changes in instrument-specific credit risk 0                          
Balance (in shares) at Sep. 30, 2019         8,000,000 451,692,000                
Balance at Sep. 30, 2019 3,403,426       $ 80 $ 4,517 3,634,140   (637,161)     401,850    
Increase (Decrease) in Stockholders' Equity                            
Adjustments related to tax withholding for share-based compensation           $ 2,600                
Shares paid for tax withholding for share based compensation (in shares)           370,244                
Balance (in shares) at Mar. 31, 2019         8,000,000 450,483,000                
Balance at Mar. 31, 2019 3,404,531       $ 80 $ 4,505 3,622,636   (637,286)     414,596    
Increase (Decrease) in Stockholders' Equity                            
Net income/(loss) 93,040               93,040          
Issuance of stock, net of expenses (in shares)           139,000                
Issuance of stock, net of expenses 586         $ 1 585              
Equity based compensation expense 2,438           2,438              
Accrued dividends attributable to stock-based awards (260)           (260)              
Dividends declared on common stock (90,124)               (90,124)          
Dividends declared on preferred stock (3,750)               (3,750)          
Dividends attributable to dividend equivalents (276)               (276)          
Change in unrealized gains on MBS, net 17,637                     17,637    
Derivative hedging instrument fair value changes and amortization, net (20,449)                     (20,449)    
Balance (in shares) at Jun. 30, 2019         8,000,000 450,622,000                
Balance at Jun. 30, 2019 3,403,373       $ 80 $ 4,506 3,625,399   (638,396)     411,784    
Increase (Decrease) in Stockholders' Equity                            
Net income/(loss) 95,599               95,599          
Issuance of stock, net of expenses (in shares)           1,070,000                
Issuance of stock, net of expenses 7,724         $ 11 7,713              
Equity based compensation expense 1,288           1,288              
Accrued dividends attributable to stock-based awards (260)           (260)              
Dividends declared on common stock (90,338)               (90,338)          
Dividends declared on preferred stock (3,750)               (3,750)          
Dividends attributable to dividend equivalents (276)               (276)          
Change in unrealized gains on MBS, net (9,016)                     (9,016)    
Derivative hedging instrument fair value changes and amortization, net (918)                     (918)    
Changes in fair value of financing agreements at fair value due to changes in instrument-specific credit risk 0                          
Balance (in shares) at Sep. 30, 2019         8,000,000 451,692,000                
Balance at Sep. 30, 2019 3,403,426       $ 80 $ 4,517 3,634,140   (637,161)     401,850    
Balance (in shares) at Dec. 31, 2019       0 8,000,000 452,369,000                
Balance at Dec. 31, 2019 3,383,952     $ 0 $ 80 $ 4,524 3,640,341   (631,040)     370,047 $ (8,326) $ (8,326)
Increase (Decrease) in Stockholders' Equity                            
Net income/(loss) (908,995)               (908,995)          
Issuance of stock, net of expenses (in shares)       11,000,000   1,106,000                
Issuance of stock, net of expenses 687 $ 266,029   $ 110   $ 7 680 $ 265,919            
Repurchase of shares of common stock (in shares) [2]           (337,000)                
Repurchase of shares of common stock [2] (2,652)           (2,652)              
Equity based compensation expense 1,266           1,266              
Accrued dividends attributable to stock-based awards 1,059           1,059              
Change in unrealized gains on MBS, net (243,812)                     (243,812)    
Derivative hedging instrument fair value changes and amortization, net (48,533)                     (48,533)    
Balance (in shares) at Mar. 31, 2020       11,000,000 8,000,000 453,138,000                
Balance at Mar. 31, 2020 2,440,675     $ 110 $ 80 $ 4,531 3,906,613   (1,548,361)     77,702    
Balance (in shares) at Dec. 31, 2019       0 8,000,000 452,369,000                
Balance at Dec. 31, 2019 3,383,952     $ 0 $ 80 $ 4,524 3,640,341   (631,040)     370,047 $ (8,326) $ (8,326)
Increase (Decrease) in Stockholders' Equity                            
Net income/(loss) (725,207)                          
Dividends declared on preferred stock (21,578)                          
Changes in fair value of financing agreements at fair value due to changes in instrument-specific credit risk (22,652)                          
Balance (in shares) at Sep. 30, 2020       11,000,000 8,000,000 453,333,000                
Balance at Sep. 30, 2020 2,565,656     $ 110 $ 80 $ 4,533 3,924,584   (1,408,910)     45,259    
Increase (Decrease) in Stockholders' Equity                            
Adjustments related to tax withholding for share-based compensation           $ 2,700                
Shares paid for tax withholding for share based compensation (in shares)           337,026                
Balance (in shares) at Mar. 31, 2020       11,000,000 8,000,000 453,138,000                
Balance at Mar. 31, 2020 2,440,675     $ 110 $ 80 $ 4,531 3,906,613   (1,548,361)     77,702    
Increase (Decrease) in Stockholders' Equity                            
Net income/(loss) 96,578               96,578          
Issuance of stock, net of expenses (in shares)           106,000                
Issuance of stock, net of expenses 37         $ 1 36              
Equity based compensation expense 1,709           1,709              
Change in unrealized gains on MBS, net (96,021)                     (96,021)    
Derivative hedging instrument fair value changes and amortization, net 64,032                     64,032    
Warrants Issued 14,041                          
Balance (in shares) at Jun. 30, 2020       11,000,000 8,000,000 453,244,000                
Balance at Jun. 30, 2020 2,521,051     $ 110 $ 80 $ 4,532 3,922,399   (1,451,783)     45,713    
Increase (Decrease) in Stockholders' Equity                            
Net income/(loss) 87,210               87,210          
Issuance of stock, net of expenses (in shares)           89,000                
Issuance of stock, net of expenses 1         $ 1                
Equity based compensation expense 2,266           2,266              
Accrued dividends attributable to stock-based awards (81)           (81)              
Dividends declared on common stock (22,667)               (22,667)          
Dividends declared on preferred stock (8,219) $ (10,328) [3] $ (11,250)             $ (10,328) $ (11,250)      
Dividends attributable to dividend equivalents (92)               (92)          
Change in unrealized gains on MBS, net 15,022                     15,022    
Derivative hedging instrument fair value changes and amortization, net 7,176                     7,176    
Changes in fair value of financing agreements at fair value due to changes in instrument-specific credit risk (22,652)                     (22,652)    
Balance (in shares) at Sep. 30, 2020       11,000,000 8,000,000 453,333,000                
Balance at Sep. 30, 2020 $ 2,565,656     $ 110 $ 80 $ 4,533 $ 3,924,584   $ (1,408,910)     $ 45,259    
[1] For the nine months ended September 30, 2019, includes approximately $2.6 million (370,244 shares) surrendered for tax purposes related to equity-based compensation awards.
[2] For the nine months ended September 30, 2020 includes approximately $2.7 million (337,026 shares) surrendered for tax purposes related to equity-based compensation awards.
[3] Includes reinstated dividends that were unpaid through June 30, 2020, and were paid during the three months ended September 30, 2020 (see Note11(a)).